Additionally, our findings revealed that having higher plasma SDF-1 levels were associated with an increased risk of recurrent stroke and cardiovascular events at two years in patients with diabetes mellitus, although this association was not as strong as observed for outcomes at one year. Here, CXCL12 is linked to Stroke.